T2 Biosystems, Inc. (Nasdaq:TTOO) announced on 5/30/18 that it is commencing an underwritten registered public offering of 5,650,000 shares of its common stock. T2 Biosystems also intends to grant the underwriters a 30-day option to purchase up to an additional 847,500 shares of its common stock. All of the shares are being offered by T2 Biosystems.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,